期刊
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
卷 72, 期 6, 页码 992-1002出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2015.02.1116
关键词
atopic dermatitis; lymphoma; neoplasm; pimecrolimus; systematic review; tacrolimus; topical corticosteroids
类别
Background: There is controversy regarding a potential increased risk of lymphoma in patients with atopic dermatitis (AD). Objective: To assess the risk of lymphoma and the role of topical treatments in patients with AD. Methods: A systematic literature search and a separate meta-analysis were performed on case control and cohort studies. Results: Of the 3979 articles retrieved, 24 references met the inclusion criteria. In cohort studies, the risk of lymphoma was slightly increased, with a relative risk (RR) of 1.43 (95% confidence interval [CI], 1.12-1.81). In case control studies, no significant increased risk of lymphoma was found, with an odds ratio (OR) of 1.18 (95% CI, 0.94-1.47). Severity of AD was a significant risk factor. Highly potent topical steroids were associated with an increased risk of lymphoma. For topical calcineurin inhibitors (TCIs), a significant association between tacrolimus and mostly skin lymphoma was found in 1 study. Limitations: Confusion between severe AD and cutaneous T-cell lymphoma may account for part of the increased risk of lymphoma in patients with AD. Conclusion: This systematic literature review shows a slightly increased risk of lymphoma in patients with AD. Severity of AD appears to be a significant risk factor. The role of topical steroids and TCIs is unlikely to be significant.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据